Literature DB >> 18355815

The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection.

Alessandro Zerbini1, Massimo Pilli, Carolina Boni, Paola Fisicaro, Amalia Penna, Paola Di Vincenzo, Tiziana Giuberti, Alessandra Orlandini, Giuseppina Raffa, Teresa Pollicino, Giovanni Raimondo, Carlo Ferrari, Gabriele Missale.   

Abstract

BACKGROUND & AIMS: Hepatitis B virus (HBV) DNA detection in serum and/or in the liver of hepatitis B surface antigen (HBsAg)-negative patients with or without serologic markers of previous viral exposure is defined as occult HBV infection. Because the role of the adaptive response in keeping HBV replication under control in occult infection still is undefined, this study was performed to characterize the features of the HBV-specific T-cell response in this condition.
METHODS: HBV-specific T-cell frequency and function were tested ex vivo and after in vitro expansion in 32 HBsAg-negative patients undergoing diagnostic liver biopsy for chronic hepatitis C: 18 with occult HBV infection (11 anti-HBc-negative and 7 anti-HBc-positive patients) defined by the detection of intrahepatic HBV DNA by polymerase chain reaction; 14 without detectable intrahepatic HBV DNA (5 anti-HBc-positive and 9 anti-HBc-negative patients). Six patients with chronic hepatitis B and 7 HBsAg-inactive carriers were studied for comparison.
RESULTS: The presence or absence of serologic HBV markers defined 2 profiles of HBV-specific T-cell responses in occult infection. Anti-HBc-positive patients showed a T-cell response typical of protective memory, suggesting that this condition represents a resolved infection with immune-mediated virus control. In contrast, HBV-specific T cells in anti-HBc-negative patients did not readily expand and produce interferon-gamma in vitro, suggesting the possibility of a low-dose infection insufficient to allow maturation of protective memory.
CONCLUSIONS: Our results suggest different mechanisms of control of viral replication in seropositive and seronegative occult infections. Additional studies aimed at understanding possible different clinical implications are needed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18355815     DOI: 10.1053/j.gastro.2008.02.017

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  44 in total

1.  Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients.

Authors:  C S Coffin; P G Stock; L M Dove; C L Berg; N N Nissen; M P Curry; M Ragni; F G Regenstein; K E Sherman; M E Roland; N A Terrault
Journal:  Am J Transplant       Date:  2010-03-19       Impact factor: 8.086

2.  Reactivation of hepatitis B virus infection following ruxolitinib treatment in a patient with myelofibrosis.

Authors:  G Caocci; F Murgia; L Podda; A Solinas; S Atzeni; G La Nasa
Journal:  Leukemia       Date:  2013-08-09       Impact factor: 11.528

Review 3.  Genetic variation of occult hepatitis B virus infection.

Authors:  Hui-Lan Zhu; Xu Li; Jun Li; Zhen-Hua Zhang
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

4.  Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy.

Authors:  Andrea Costantini; Katia Marinelli; Giulia Biagioni; Alessia Monachetti; Monica L Ferreri; Luca Butini; Maria Montroni; Aldo Manzin; Patrizia Bagnarelli
Journal:  BMC Infect Dis       Date:  2011-11-04       Impact factor: 3.090

5.  High Prevalence of Hepatitis B Virus Infection in Young Adults in Ternate, Eastern Indonesia.

Authors:  Susan Irawati Ie; Erick Sidarta; Arkasha Sadhewa; Gludhug Ariyo Purnomo; Yuyun S M Soedarmono; Mochtar Zein Pattiiha; Meta Dewi Thedja; Alida R Harahap; David H Muljono
Journal:  Am J Trop Med Hyg       Date:  2015-09-21       Impact factor: 2.345

6.  A pilot study of serum microRNA signatures as a novel biomarker for occult hepatitis B virus infection.

Authors:  Yuanyuan Chen; Limin Li; Zhenxian Zhou; Nan Wang; Chen-Yu Zhang; Ke Zen
Journal:  Med Microbiol Immunol       Date:  2012-03-06       Impact factor: 3.402

Review 7.  Occult hepatitis B virus infection in Egypt.

Authors:  Ashraf Elbahrawy; Alshimaa Alaboudy; Walid El Moghazy; Ahmed Elwassief; Ahmed Alashker; Abdallah Mahmoud Abdallah
Journal:  World J Hepatol       Date:  2015-06-28

8.  Clinical features of adverse reactions associated with telbivudine.

Authors:  Xue-Song Zhang; Rui Jin; Shi-Bin Zhang; Ming-Ling Tao
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

9.  Detection of hepatitis B virus DNA among accepted blood donors in Nanjing, China.

Authors:  Yong Liu; Ping Li; Cuiping Li; Jinyong Zhou; Chao Wu; Yi-Hua Zhou
Journal:  Virol J       Date:  2010-08-19       Impact factor: 4.099

10.  Programmed death-1 expression is associated with the disease status in hepatitis B virus infection.

Authors:  Pian Ye; Zhi-Hong Weng; Shu-Ling Zhang; Jian-Ao Zhang; Lei Zhao; Ji-Hua Dong; Sheng-Hua Jie; Ran Pang; Rong-Hua Wei
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.